
Sign up to save your podcasts
Or
A conversation with Jonathan A. C. Sterne, MA, MSc, PhD, of the University of Bristol, Todd W. Rice, MD, MSc, of Vanderbilt University, and Janet V. Diaz, MD, of the World Health Organization (WHO) on the latest research supporting the use of hydrocortisone and dexamethasone for treatment of COVID-19 ARDS. Recorded September 2, 2020.
Related Article(s):
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
4.6
162162 ratings
A conversation with Jonathan A. C. Sterne, MA, MSc, PhD, of the University of Bristol, Todd W. Rice, MD, MSc, of Vanderbilt University, and Janet V. Diaz, MD, of the World Health Organization (WHO) on the latest research supporting the use of hydrocortisone and dexamethasone for treatment of COVID-19 ARDS. Recorded September 2, 2020.
Related Article(s):
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
756 Listeners
38,560 Listeners
135 Listeners
315 Listeners
21,669 Listeners
865 Listeners
495 Listeners
43,334 Listeners
6,688 Listeners
686 Listeners
3,321 Listeners
17 Listeners
18 Listeners
13 Listeners
23 Listeners
6 Listeners
90 Listeners
29 Listeners
195 Listeners
349 Listeners
6,210 Listeners
18 Listeners